The renal response to FGF23 shifts from phosphaturia towards inflammation in kidney disease
Matthias B. Moor, Mikhail Burmakin, Anna Levin…·Hannes Olauson
This study shows that excess FGF23 drives inflammation in kidney disease models and human data, suggesting it as a therapeutic target.